Canakinumab Treat-To Target Strategies Increase Complete Response Rate in CAPS

Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-13-s1-p173
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

P02-008 - Dramatic Response to Canakinumab in MKD

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

Treat-To-Target Bei Gicht Unerlässlich

CME
Family Practice
2015English

Treat-To-Target: Therapeutische Ziele/Prognoseparameter

Zeitschrift fur Rheumatologie
Rheumatology
2019English

Treat-To-Target in PsA: Methods and Necessity

RMD Open
RheumatologyAllergyImmunology
2020English

Spondyloarthritis: Empfehlung Für Treat-To-Target Aktualisiert

Orthopädie & Rheuma
2017English

Treat-To-Target Ist Bei Gicht Unerlässlich

Orthopädie & Rheuma
2016English

Objective Evaluation for Treat to Target in Crohn’s Disease

Journal of Gastroenterology
Gastroenterology
2020English

Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions

Rheumatology and Therapy
2019English

Strategies to Increase Student Interest in Aging

Journal of Gerontological Social Work
Social WorkNursingSocial Sciences
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy